Polymorphism in piroxicam

Crystal Growth and Design

Volumn 4, Issue 6, 2004, Pages 1091-1098

  Shet, Agam R ^a   Bates, Simon ^b   Muller, Francis X ^c   Grant, David J W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SSCI Incorporated   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIROXICAM;

AB INITIO CALCULATION; ARTICLE; CONFORMATION; CRYSTALLIZATION; DRUG STRUCTURE; ENERGY; HYDROGEN BOND;

EID: 8844272595     PISSN: 15287483     EISSN: None     Source Type: Journal    
DOI: 10.1021/cg049876y     Document Type: Article

References (36)

1. The Merck Index, 13th ed.; Merck & Co., Inc.: Whitehouse Station, NJ, 2001; p 7588.
2. (b) Majerus, P. W.; Broze, G. J.; Miletich, J. P.; Tollefsen, D. M. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J. G., Limbird, L. E., Eds.; McGraw-Hill: New York, 1996; pp 640-641.
3. Mihalic, M.; Hofman, H.; Kajfez, F.; Kuftinec, J.; Blazevic, N.; Zinic, M. Physicochemical and analytical characteristics of piroxicam. Acta Pharm. Jugosl. 1982, 32, 13-20.
4. Kozjek, F.; Golic, L.; Zupet, P.; Palka, E.; Vodopivec, P.; Japelj, M. Physicochemical properties and bioavailability of two crystal forms of piroxicam. Acta Pharm. Jugosl. 1985, 35, 275-281.
5. Mihalic, M.; Hofman, H.; Kuftinec, J.; Krile, B.; Caplar, V.; Kajfez, F.; Blazevic, N. Piroxicam. Anal. Profiles Drug Subst. 1986, 15, 509-531.
6. Vrecer, F.; Srcic, S.; Smid-Korbar, J. Investigation of piroxicam polymorphism. Int. J. Pharm. 1991, 68, 35-41.
7. Csoka, G.; Balogh, E.; Marton, S.; Farkas, E.; Racz, I. Examination of the polymorphism of piroxicam in connection with the preparation of a new "soft-patch" type pharmaceutical dosage form. Drug. Dev. Ind. Pharm. 1999, 25 (6), 813-816.
8. 6,2-benzothiazine-3- carboxamide-1,1-dioxide (piroxicam). Acta Crystallogr. 1982, B38, 2948-2951.
9. Reck, G.; Dietz, G.; Laban, G.; Gunther, W.; Bannier, G.; Hohne, E. X-ray studies on piroxicam modifications. Pharmazie 1988, 43, 477-481.
10. Cambridge Crystallographic Data Center. The Cambridge Structural Database; University Chemical Laboratory: Cambridge, United Kingdom, 1996.
11. (b) Allen, F. H. The Cambridge Structural Database: A quarter of a million crystal structures and rising. Acta Crystallogr. 2002, B58, 380-388.
12. (c) Allen, F. H.; Motherwell, W. D. S. Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry. Acta Crystallogr. 2002, B58, 407-422.
13. (d) Bruno, I. J.; Cole, J. C.; Edgington, P. R.; Kessler, M.; Macrae, C. F.; McCabe, P.; Pearson, J.; Taylor, R. New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr. 2002, B58, 389-397.
14. Version 2.2; Cambridge Crystallographic Data Center: 2003.
15. SSCI Indexing Program, Version 1.3.4; SSCI, Inc.: 2004.
16. Vrecer, F.; Vrbinc, M.; Meden, A. Characterization of piroxicam crystal modifications. Int. J. Pharm. 2003, 256, 3-15.
17. Reck, G.; Laban, G. Prediction and establishment of a new crystalline piroxicam modification. Pharmazie 1990, 45, 257-259.
18. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, revision A.1; Gaussian, Inc.: Pittsburgh, PA, 2003.
19. Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98 (7), 5648-5652.
20. Bernstein, J. Polymorphism in Molecular Crystals; Clarendon Press: Oxford, United Kingdom, 2002.
21. Yu, L.; Stephenson, G. A.; Mitchell, C. A.; Bunnell, C. A.; Snorek, S. V.; Bowyer, J. J.; Borchardt, T. B.; Stowell, J. G.; Byrn, S. R. Thermochemistry and conformational polymorphism of a hexamorphic crystal system. J. Am. Chem. Soc. 2000, 122, 585-591.
22. Taddei, P.; Torreggiani, A.; Simoni, R. Influence of environment on piroxicam polymorphism: vibrational spectroscopic study. Biopolymers (Biospectroscopy) 2001, 62, 68-78.
23. Janik, M.; Malarski, Z.; Mrozinski, J.; Wajcht, J.; Zborucki, Z. Influence of solvent effect on polymorphism of 4-hydroxy-2-methyl-N-2-pyridyl- 2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide (piroxicam). J. Crystallogr. Spectrosc. Res. 1991, 21 (4), 519-522.
24. Bernstein, J. Conformational polymorphism. III. The crystal and molecular structures of the second and third forms of iminodiacetic acid. Acta Crystallogr. 1979, B35, 360-366.
25. Etter, M. C. Aggregate structures of carboxylic acids and amides. Isr. J. Chem. 1985, 25, 312-319.
26. (b) Etter, M. C. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc. Chem. Res. 1990, 23, 120-126.
27. (c) Etter, M. C. Hydrogen bonds as design elements in organic chemistry. J. Phys. Chem. 1991, 95, 4601-4610.
28. (d) Etter, M. C.; MacDonald, J. C.; Bernstein, J. Graph-set analysis of hydrogen-bond patterns in organic crystals. Acta Crystallogr. 1990, B46, 256-262.
29. (e) Etter, M. C.; Urbanczyk-Lipkowska, Z.; Zia-Ebrahimi, M.; Panunto, T. W. Hydrogen bond directed cocrystallization and molecular recongnition properties of diarylureas. J. Am. Chem. Soc. 1990, 112, 8415-8426.
30. (f) Bernstein, J.; Davies, R. E.; Shimoni, L.; Chang, N. Angew. Chem., Int. Ed. Engl. 1995, 34, 1555.
31. (g) Grell, J.; Bernstein, J.; Tinhofer, B. Graph-set analysis of hydrogen-bond patterns: some mathematical concepts. Acta Crystallogr. 1999, B55, 1030-1043.
32. Redenti, E.; Peveri, T.; Zanol, M.; Ventura, P.; Gnappi, G.; Montenero, A. A study of the differentiation between amorphous piroxicam:β- cyclodextrin complex and a mixture of the two amorphous components. Int. J. Pharm. 1996, 129, 289-294.
33. The United States Pharmacopoeia XXVII, USP27/NF22, 27th revision; The United States Pharmacopoeial Convention, Inc.: Rockville, MD, 2004; p 1499.
34. Crowley, K. J.; Zografi, G. Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci. 2002, 91 (2), 492-507.
35. Lutteroti, L. Material Analysis Using X-ray Diffraction (MAUD), version 1.998; Department of Materials Engineering, University of Trento: Italy.
36. Billinge, S. J. L.; Thorpe, M. F. Local Structure from Diffraction; Plenum Press: New York, 1998.